Tumor Immunogenomic Profiling: High-Content Assays and Analytics
Few platforms support multidimensional biomarker analysis. This talk will highlight ACE ImmunoID™ as a universal platform for biomarker discovery that enables comprehensive variant detection, neoantigen identification, and characterization of tumor immunogenomics. We will feature a case study demonstrating the platform’s ability to identify tumor escape mechanisms for cancer immunotherapy.
